Criteria for Meeting Endorsement

Athanasios J. Manolis, Krzysztof Narkiewicz, Sverre E. Kjeldsen, Renata Cifková, and Giuseppe Mancia for the ESH Council

The aim of the ESH is threefold:

  1. To disseminate the latest information regarding optimal approaches for diagnosis and management of hypertension
  2. To provide a forum for presentation of research by investigators
  3. To provide training and credentialing of hypertensive specialists

The ESH wishes to cooperate at various levels with the National and International Hypertension Societies that share its goals, and endorse international meetings related to hypertension and cardiovascular prevention and therapy with a balanced scientific content.

Endorsement will be given by the ESH to International Meetings or Symposia with international participation if they meet the following criteria:

  1. The application should be submitted in advance to give the ESH Council member(s) sufficient time to discuss the issue.
  2. The application needs to be accompanied by the scientific program of the meeting and the roster of the speakers. It also needs to be accompanied by a short history of the meeting(s) and the scientific program(s) of the previous meeting(s).
  3. An especially-assigned ESH Council member, who is not directly involved in the meeting activity, will handle the application. An early assessment will be given to meeting organisers, i.e. if the scientific meeting fulfils the above criteria the organisers will receive a preliminary endorsement from the ESH Council member,  the assessment will be submitted at the next ESH Council meeting for formal approval.
  4. Pre- or Post-Congress Satellite Symposia of the ESH meetings and ESH Teaching Faculty Symposia will be automatically endorsed.

Applications should be sent to:

Prof. Philippe van de Borne
philippe.van.de.borne@erasme.ulb.ac.be

ESH website:

All meetings endorsed by the ESH will be displayed on the Society’s website, so people from different countries may be informed in advance and decide whether they would like to participate.


Meetings Endorsed by ESH

The following meetings have been endorsed by the European Society of Hypertension:

2017

1. Age and Gender Factors in Hypertension, 21-22 April 2017

2016

1. 2nd Gulf Hypertension Conference, Dubai, U.A.E., 27-28 January 2016

2. Diastole Diseased DD-2016, Pisa, Italy, 3-5 March 2016

3. 4th International Conference on Prehypertension, Hypertension and Cardiometabolic Syndrome, Venice, Italy, 3-6 March
2016

4. ESH Master Course, Marrakesh, Morocco, 30 September-1 October 2016

5. International Symposium: Strategies to Redue Morbidity and Premature CV Mortality in Latin America, 17-18 October 2016

6. 4th India Risk Factor Symposium, 22-23 October 2016

7. International Symposium: Uric Acid Cardiovascular Disease: Back to Pathophysiology, 1-3 December 2016

8. Salt, Hypertension and Stroke, 2-3 December 2016

2015

1. International Symposium on Management of Cardiometabolic Risk and Healthy Aging, Brescia, Italy, 15-17 January 2015

2. First Gulf Hypertension Conference, Dubai, U.A.E., 26-27 Janaury 2015

3. 9th International Meeting on Hypertension and Cardiovascular Risk, Portuguese Society of Hypertension, Vilamoura,
Algarve, 26 February-1 March 2015

4. Cardiology-Innovations Toward the Future, Bangkok, Thailand, 26-27 March 2015

5. Master Class on Microcirculation, Rhodes, Greece, 29-30 April 2015

6. 3rd India Risk Factor Symposium Goa, India, 2-3 October 2015

7. Algerian Congress on Hypertension, Alger, Algeria, 24-25 October 2015

8. ESH Practical Intensive Course on Hypertension and Cardiovascular Risk, Almaty, Kazakhstan, 30-31 October 2015

9. Arterial Stiffness and Early Vascular Aging, 4th Edition, Braga, Portugal, 18-19 November 2015

10. Lithuanian Forum on Hypertension, Vilnius, Lithuania, 20-21 November 2015

11. International Symposium on the Complexity of the Management of Hypertension and its Comorbidities, Barcelona, Spain,
26-28 November 2015

12. First National  Meeting on Fibromuscular Dysplasia, Brussels, Belgium, 12 December 2015

13. Educational Project: Experience, Barcelona, Spain, Prof. Antonio Coca

2014

1. 7th Central European Meeting on Hypertension and 4th Serbian Society of Hypertension Meeting, Belgrade, Serbia, 20-23
March 2014

2. Arterial Stiffness and Early Vascular Ageing, Minho, Portugal, 2-4 April 2014

3. ESGCO 2014 Meeting, Fai della Paganella, Trento, Italy, 28-31 May 2014

4. Facts and Doubts in Hypertension, 3rd Congress of the Romanian Society of Hypertension, Bucharest, Romania, 18-20
September 2014

5. Artery 14, Maastricht, Netherlands, 9-11 October 2014

6. From Gout to Cardiovascular Disease: a central role for uric acid, Bologna, Italy, 6-8 November 2014

7. Third International Symposium on Hypertension ISHOP3 – Translational Medicine in Hypertension, Osijek, Croatia-Pécs,
Hungary, 27-30 November 2014

Pre-Congress Satellite Symposia of the 2014 Athens ESH meeting:

1. Obesity, diabetes and the high risk patient, Thessaloniki, Greece, 7-8 June 2014

2. Update on Resistant hypertension and related comorbidities, Athens, Greece, 11-12 June 2014

2013

1. Paths To Treatment, Naples, Italy, September 13-14 2013

2. 5th International Conference on Fixed Combination, Bangkok, Thailand, 21-24 November 2014

3. SSIF International Conference: 2nd European-Middle East Forum on Managing Cardiovascular Risk Factors in Clinical
Practice, Istanbul, Turkey, 6 December 2013

2011

1. 2nd International Meeting of the Hellenic Society of Hypertension and CV Prevention in Collaboration with National
Societies of Serbia, Croatia, Slovenia, Bulgaria, Cyprus, Turkey, Athens, January 27-29, 2011

2. Bahrain Panarab and ESH Conference, Bahrain, February 11-13, 2011

3. XII International Forum for the Evaluation of Cardiovascular Care, Budapest, Hungary, March 24-26, 2011

4. 8th Mediterranean Meeting on Hypertension and Atherosclerosis, Marmaris, Turkey, April 6-10, 2011

5. Cross Examining Contemporary Issues in Hypertension: Controversy or Consensus, Barcelona, Spain, May 14, 2011

6. Pre- and Post- Congress Satellite Symposia of the ESH XXI Meeting, on 16-17 June, including one Chinese Satellite
Symposium planned in Milan, Italy on June 21, 2011

7. 6th Central European Meeting on Hypertension, Bratislava, Slovakia, October 22-25, 2011

8. World Hypertension League Regional Congress 2011 and International Symposium on Hypertension and Related Diseases,
Beijing, China, November 3-6, 2011

9. 8th Asian-Pacific Congress on Hypertension, Taiwan, Taipei, November 24-27, 2011

2010

1. The International Conference on Early Disease Detection and Prevention, Munich, Germany, 25-28 February, 2010

2. 2nd Congress of the Serbian-Croatian Society of Hypertension, Belgrade, Serbia, 26-28 February, 2010

3. XI International Forum for the Evaluation of Cardiovascular Care, Prague, Czech Republic, 18-20 March, 2010

4. 7th Mediterranean Meeting on Hypertension and Atherosclerosis, Cappodocia, Turkey, 14-18 April, 2010

5. II Interactive Meeting on Agina, Athens, Greece, 15-16 April, 2010

6. IV Baltic Hypertension Congress-Satellite Symposium to the 20th European Meeting on Hypertension, Tallinn, Estonia,
22-24 April, 2010

7. Update ESH Guidelines – China Express Project, Beijing, China, April, 2010

8. 2nd Symposium “Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics II”- Satellite Sypmposium to the
20th European Meeting on Hypertension, Thessaloniki, Greece, 4-5 June, 2010

9. Hypertension with Subclinical and clinical organ damage: Therapeutic Approach-Satellite Symposium to the 20th European
Meeting on Hypertension, Costa Navarino, Greece, 15-18 July, 2010

10. 2nd International Symposium on Hypertension Translational Medicine in Hypertension – Croatian and Hungarian Society of
Hypertension, Osijec, Croatia, 19-21 November, 2010

2009

1. Interactive Teaching Course: Microalbuminuria, Italy, May 19, 2009

2007

1. Prevalence, diagnosis and treatment of primary aldosteronism. Satellite Symposium of the ESH meeting, Padua, June, 2007

2. 1st International Portuguese Hypertension Meeting Villamoura, Algarve, Portugal, February 8-11,2007

3. XIth World Congress of Echocardiography and Cardiovascular Ultrasound and 1st International Congress on Hypertension
and Cardiovascular Prevention Rhodes, Greece, June 29-July 1st, 2007

2006

1. Satellite Symposium of the ESH meeting. ‘New insights in the pathophysiology and treatment of hypertension’ Pisa, Italy,
May 24, 2006, Prof A. Salvetti

2. Satellite Symposium of the ESH meeting ‘Treating hypertensive patients with multiple risk factors’ Myconos, Greece, July 1,
2006, Prof. A. J. Manolis

3. XIV International Symposium on Atherosclerosis. Rome, Italy, June 18-22, 2006

4. Joint Symposium of the Czech Society of Hypertension and the Belgian Society of Hypertension. Marianske Lazne, Czech Republic, October 7, 2006

5. XXII World Congress of the International Union of Angiology. Lisbon, Portugal, June 24-26, 2006. Prof. Novo, Prof.
Fernandes

6. Role of ACE-inhibitors in Cardiovascular Prevention. Istanbul, Turkey, July, 6-7, 2006. Prof. S. Erdine, Prof. C. Borghi

7. 3rd Mediterranean Meeting on Hypertension and Atherosclerosis. Antalya, Turkey, 2006. Prof. S. Erdine

8. 2nd International Meeting on the Renin-Angiotensin System. Riga, Latvia, May 25-26, 2006

9. 6th Artery Meeting. Athens, Greece, September 22-23, 2006

2005

1. 1st International Summit on Intra-Abdominal Adiposity and Related Comorbidities. Madrid, Spain, July 1-3, 2006

2. The Failing Heart Under Stress. Amsterdam, Holland, November, 20-22, 2006

3. 2nd Mediterranean Meeting on Hypertension and Atherosclerosis. Antalya, Turkey, April 2006. Prof. S. Erdine

2004

1. 1st Mediterranean Meeting on Hypertension and Atherosclerosis. Antalya, Turkey, April 2004. Prof. S. Erdine